Article Per Year (5 Year)
p-Index From 2021 - 2026
0.61
P-Index
This Author published in this journals
All Journal JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Generics: Journal of Research in Pharmacy Generics : Journal of Research in Pharmacy
Susi Ari Kristina
Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia
Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Education Health Professions Medicine & Pharmacology Other

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Perception of Hospital Pharmacist on Working Performance in Yogyakarta Province, Indonesia Dona Muin; Satibi Satibi; Susi Ari Kristina; Yayi Suryo Prabandari
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 10 No. 2 (2023): JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v10i22023.235-245

Abstract

Background: Pharmacists support the success of hospital in efforts to improve people's quality of life then the performance measurement of pharmacists is carried out. Objectives: This study aimed to measure pharmacist performance based on the perception of pharmacists working in hospitals. Methods: Perception surveys were conducted with pharmacists working in public hospitals. The assessment was performed using a closed questionnaire that was proven to be valid and reliable. This study evaluated pharmacists' perceptions of their work performance and their ability to perform their roles, duties, and functions in the hospital. A total of 192 pharmacist respondents answered 61 statements in the questionnaire that were divided into 11 dimensions as follows:1) the objectives set; 2) following the procedure; 3) initiatives; 4) performing the main task; 5) the ability to cooperate; 6) out implementing pharmaceutical standards; 7) the potential for solving problems; 8) quick response; 9) self-competence; 10) the ability to take verbal orders and writing; and 11)  endurance at work. Results: The various answers of respondents to the questionnaire led to the conclusion that pharmacists' performance in hospitals is included in the high-performance category. Conclusion: This study showed that pharmacists have a high perception of their ability to work, as outlined in their assessment of their work performance in hospitals. Pharmacists' perceptions of their workplace performance in public hospitals are useful for developing pharmaceutical services. The results of this study are expected to provide a basis for improving the performance of pharmacists working in hospitals, especially hospitals in the Yogyakarta area.
Acceptance and Willingness to Pay for Cardiovascular Disease Screening: A Systematic Review Amalia Hanifti Choirunisa; Susi Ari Kristina; Nanang Munif Yasin
Generics: Journal of Research in Pharmacy Vol 6, No 2 (2026): Generics : Journal of Research in Pharmacy
Publisher : Faculty of Medicine, Diponegoro University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.14710/genres.v6i2.26743

Abstract

Cardiovascular Disease (CVD) ranks as the highest economic burden; many individuals remain undiagnosed due to the absence of a structured screening program or lack of early-stage treatment. Willingness to Pay (WTP) is a method used to assess consumers' preference for a product or service by evaluating their financial capacity and willingness to pay within a given population. This systematic review aimed to examine studies of WTP and factors influencing CVD screening. The required articles were collected by searching for relevant keywords in PubMed, Scopus, and Google Scholar. This systematic review was conducted using the PRISMA method. Seven studies were included in the review. Most participants were aged above 55 years, and 50% were diagnosed with early-stage hypertension. The WTP ranged from US$ 10 to US$ 500 per annual screening test. The results of reviewed studies indicate a relatively high level of acceptance for CVD screening. Family history and perception of risk are the most significant factors, besides cost. These findings can serve as a valuable reference for policymakers in implementing effective public health interventions. By developing and promoting screening programs, governments can enhance preventive measures to reduce the morbidity and mortality associated with CVD. 
Acceptance and Willingness to Pay for Cardiovascular Disease Screening: A Systematic Review Amalia Hanifti Choirunisa; Susi Ari Kristina; Nanang Munif Yasin
Generics: Journal of Research in Pharmacy Vol 6, No 2 (2026): Generics : Journal of Research in Pharmacy
Publisher : Faculty of Medicine, Diponegoro University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.14710/genres.v6i2.26743

Abstract

Cardiovascular Disease (CVD) ranks as the highest economic burden; many individuals remain undiagnosed due to the absence of a structured screening program or lack of early-stage treatment. Willingness to Pay (WTP) is a method used to assess consumers' preference for a product or service by evaluating their financial capacity and willingness to pay within a given population. This systematic review aimed to examine studies of WTP and factors influencing CVD screening. The required articles were collected by searching for relevant keywords in PubMed, Scopus, and Google Scholar. This systematic review was conducted using the PRISMA method. Seven studies were included in the review. Most participants were aged above 55 years, and 50% were diagnosed with early-stage hypertension. The WTP ranged from US$ 10 to US$ 500 per annual screening test. The results of reviewed studies indicate a relatively high level of acceptance for CVD screening. Family history and perception of risk are the most significant factors, besides cost. These findings can serve as a valuable reference for policymakers in implementing effective public health interventions. By developing and promoting screening programs, governments can enhance preventive measures to reduce the morbidity and mortality associated with CVD. 
Co-Authors Amalia Hanifti Choirunisa Dona Muin Nanang Munif Yasin Satibi Satibi Yayi Suryo Prabandari